Millibar (Indapamide Hemihydrate)

• Indapamide acts on the renal tubular system to manage fluid balance and blood pressure, making it useful in several cardiovascular conditions.
• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Edema: promotes diuresis to decrease excess fluid accumulation in peripheral tissues.
• Congestive heart failure: assists in fluid removal to improve symptoms of volume overload.

• Indapamide inhibits sodium and chloride reabsorption in the distal convoluted tubule of the kidney. This blockade reduces intravascular volume and peripheral vascular resistance, leading to increased urine output and a gradual decrease in blood pressure, while also improving peripheral vascular compliance.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dizziness or light‑headedness
• Headache
• Increased urinary frequency
• Electrolyte disturbances such as low potassium
• Fatigue or weakness
• Nausea or abdominal discomfort

Serious or Rare Side Effects

• Severe dehydration or electrolyte imbalance
• Allergic reactions including rash or angioedema
• Acute renal impairment
• Blood dyscrasias such as leukopenia
• Pancreatitis
• Severe hypotension leading to syncope

Before initiating therapy, clinicians should consider several safety measures.

• Monitor blood pressure regularly: ensure target levels are achieved without excessive drops.
• Check serum electrolytes: especially potassium and sodium, before and during treatment.
• Assess renal function: adjust use in patients with impaired kidney function.
• Avoid abrupt discontinuation: taper if long‑term therapy is stopped.
• Use cautiously in diabetic patients: monitor glucose as diuresis may affect control.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Lithium: risk of lithium toxicity due to reduced renal clearance.
• NSAIDs (e.g., ibuprofen): may blunt diuretic effect and worsen renal function.
• Corticosteroids: increase risk of hypokalemia and other electrolyte disturbances.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: potential for additive blood‑pressure lowering and hyperkalemia.
• Antidiabetic agents: diuresis may enhance glucose lowering, requiring dose adjustment.
• Beta‑blockers: combined antihypertensive effect may cause excessive blood‑pressure reduction.